Samanta Sennati
University of Siena
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Samanta Sennati.
Antimicrobial Agents and Chemotherapy | 2009
Lucia Pallecchi; Eleonora Riccobono; Antonia Mantella; Filippo Bartalesi; Samanta Sennati; Herlan Gamboa; Eduardo Gotuzzo; Alessandro Bartoloni; Gian Maria Rossolini
ABSTRACT A remarkable prevalence of qnrB (54%) and, at a lower level, of qnrS (14%) was discovered in pools of commensal enterobacteria from 310 healthy children living in Peru and Bolivia, using a metagenomic approach. Analysis of randomly selected enterobacterial pools revealed that qnrB was mainly carried by Escherichia coli and qnrS by Klebsiella pneumoniae. Investigation of 11 qnrB-positive isolates and 9 qnrS-positive isolates revealed the presence of plasmid-borne qnrB19 (n = 8), qnrB2 (n = 2), qnrB10 (n = 1), and qnrS1 (n = 9) genes.
Antimicrobial Agents and Chemotherapy | 2012
Samanta Sennati; Gisela Santella; J. Di Conza; Lucia Pallecchi; Marylú Pino; Barbara Ghiglione; Gian Maria Rossolini; Marcela Radice; Gabriel Gutkind
ABSTRACT A multicenter survey, carried out in 2010 in Argentina, showed an increased prevalence of extended-spectrum β-lactamase (ESBL)-producing enterobacteria, with some changes in the molecular epidemiology of circulating ESBLs. While enzymes of the CTX-M-2 group remain endemic, the emergence of CTX-M-15 and of enzymes of the CTX-M-8 and CTX-M-9 groups was observed. The CTX-M-15-positive isolates represented 40% of CTX-M producers and included representatives of Escherichia coli ST131 and Klebsiella pneumoniae ST11.
Antimicrobial Agents and Chemotherapy | 2010
Lucia Pallecchi; Eleonora Riccobono; Samanta Sennati; Antonia Mantella; Filippo Bartalesi; Christian Trigoso; Eduardo Gotuzzo; Alessandro Bartoloni; Gian Maria Rossolini
ABSTRACT In this work, we have characterized two small ColE-like plasmids (pECY6-7, 2.7 kb in size, and pECC14-9, of 3.0 kb), encoding the QnrB19 quinolone resistance determinant, that were carried by several clonally unrelated quinolone-resistant commensal Escherichia coli strains isolated from healthy children living in different urban areas of Peru and Bolivia. The two plasmids are closely related to each other and carry the qnrB19 gene as the sole resistance determinant, located in a conserved genetic context between the plasmid RNAII sequence (which controls plasmid replication) and the plasmid Xer site (involved in plasmid dimer resolution). ISEcp1-like or other putative insertion sequences are not present in the qnrB19-flanking regions or elsewhere on the plasmids. Since we previously observed a high prevalence (54%) of qnrB genes in the metagenomes of commensal enterobacteria from the same population of healthy children, the presence of pECY6-7- and pECC14-9-like plasmids in those qnrB-positive metagenomes was investigated by PCR mapping. Both plasmids were found to be highly prevalent (67% and 16%, respectively) in the qnrB-positive metagenomes, suggesting that dissemination of these small plasmids played a major role in the widespread dissemination of qnrB genes observed in commensal enterobacteria from healthy children living in those areas.
International Journal of Infectious Diseases | 2015
Alessandro Bartoloni; Eleonora Riccobono; Donata Magnelli; Ana Liz Villagran; Tiziana Di Maggio; Antonia Mantella; Samanta Sennati; Carmen Revollo; Marianne Strohmeyer; Tommaso Giani; Lucia Pallecchi; Gian Maria Rossolini
OBJECTIVES Information is lacking on the methicillin-resistant Staphylococcus aureus (MRSA) clonal lineages circulating in Bolivia. We investigated the prevalence and molecular epidemiology of S. aureus colonization in hospitalized patients from the Bolivian Chaco, and compared their features with those of the few clinical isolates available from that setting. METHODS S. aureus nasal/inguinal colonization was investigated in 280 inpatients from eight hospitals in two point prevalence surveys (2012, n=90; 2013, n=190). Molecular characterization included genotyping (spa typing, multilocus sequence typing, and pulsed-field gel electrophoresis), detection of virulence genes, and SCCmec typing. RESULTS Forty-one inpatients (14.6%) were S. aureus nasal/inguinal carriers, of whom five were colonized by MRSA (1.8%). MRSA isolates mostly belonged to spa-type t701, harboured SCCmec IVc, and were negative for Panton-Valentine leukocidin (PVL) genes. However, a USA300-related isolate was also detected, which showed the characteristics of the USA300 Latin American variant (USA300-LV; i.e., ST8, spa-type t008, SCCmec IVc, presence of PVL genes, absence of arcA). Notably, all the available MRSA clinical isolates (n=5, collected during 2011-2013) were also identified as USA300-LV. CONCLUSIONS Overall, MRSA colonization in inpatients from the Bolivian Chaco was low. However, USA300-LV-related isolates were detected in colonization and infections, emphasizing the importance of implementing control measures to limit their further dissemination in this resource-limited area.
Journal of Antimicrobial Chemotherapy | 2017
Samanta Sennati; Vincenzo Di Pilato; Eleonora Riccobono; Tiziana Di Maggio; Ana Liz Villagran; Lucia Pallecchi; Alessandro Bartoloni; Gian Maria Rossolini; Tommaso Giani
Department of Medical Biotechnologies, University of Siena, Siena, Italy; Department of Surgery and Translational Medicine, University of Florence, Florence, Italy; Department of Experimental and Clinical Medicine, University of Florence, Careggi University Hospital, Florence, Italy; Hospital B asico Villa Montes, Villa Montes, Plurinational State of Bolivia; Infectious and Tropical Diseases Unit, Florence Careggi University Hospital, Florence, Italy; Clinical Microbiology and Virology Unit, Florence Careggi University Hospital, Florence, Italy
Journal of Antimicrobial Chemotherapy | 2016
Samanta Sennati; Eleonora Riccobono; Vincenzo Di Pilato; Ana Liz Villagran; Lucia Pallecchi; Alessandro Bartoloni; Gian Maria Rossolini
Department of Medical Biotechnologies, University of Siena, Santa Maria alle Scotte University Hospital, Siena, Italy; Department of Experimental and Clinical Medicine, University of Florence, Careggi University Hospital, Florence, Italy; Department of Surgery and Translational Medicine, University of Florence, Florence, Italy; Hospital Basico Villa Montes, Villa Montes, Bolivia; Infectious and Tropical Diseases Unit, Careggi University Hospital, Florence, Italy; Clinical Microbiology and Virology Unit, Careggi University Hospital, Florence, Italy
Journal of Peptide Science | 2017
Simona Pollini; Jlenia Brunetti; Samanta Sennati; Gian Maria Rossolini; Luisa Bracci; Alessandro Pini; Chiara Falciani
Infection sustained by multidrug‐resistant and extensively drug‐resistant bacterial pathogens is often untreatable with the standard of care antibiotics, and the combination of anti‐infective compounds often represents the only therapeutic strategy to face this major clinical treat. SET‐M33 is a novel antimicrobial peptide (AMP) that has demonstrated in vitro and in vivo antimicrobial activity against Gram‐negative bacteria and has shown interesting features in preclinical evaluations. Particularly, it showed efficacy against a number of multidrug‐resistant and extensively drug‐resistant clinical strains of Gram‐negative pathogens, in in vitro and in vivo assessments.
International Journal of Infectious Diseases | 2016
Alessandro Bartoloni; Samanta Sennati; Tiziana Di Maggio; Antonia Mantella; Eleonora Riccobono; Marianne Strohmeyer; Carmen Revollo; Ana Liz Villagran; Lucia Pallecchi; Gian Maria Rossolini
BACKGROUND Bolivia is among the lowest-resourced South American countries, with very few data available on antibiotic resistance in bacterial pathogens. The phenotypic and molecular characterization of bacterial isolates responsible for urinary tract infections (UTIs) in the Bolivian Chaco are reported here. METHODS All clinical isolates from UTIs collected in the Hospital Basico Villa Montes between June 2010 and January 2014 were analyzed (N=213). Characterization included susceptibility testing, extended-spectrum beta-lactamase (ESBL) detection, identification of relevant resistance determinants (e.g., CTX-M-type ESBLs, 16S rRNA methyltransferases, glutathione S-transferases), and genotyping of CTX-M producers. RESULTS Very high resistance rates were observed. Overall, the lowest susceptibility was observed for trimethoprim-sulphamethoxazole, tetracycline, nalidixic acid, amoxicillin-clavulanic acid, ciprofloxacin, and gentamicin. Of E. coli and K. pneumoniae, 11.6% were ESBL producers. Resistance to nitrofurantoin, amikacin, and fosfomycin remained low, and susceptibility to carbapenems was fully preserved. CTX-M-15 was the dominant CTX-M variant. Four E. coli ST131 (two being H30-Rx) were identified. Of note, isolates harbouring rmtB and fosA3 were detected. CONCLUSIONS Bolivia is not an exception to the very high resistance burden affecting many South American countries. Optimization of alternative approaches to monitor local antibiotic resistance trends in resource-limited settings is strongly encouraged to support the implementation of effective empiric treatment guidelines.
Antimicrobial Agents and Chemotherapy | 2018
Avgoulea K; Di Pilato; Zarkotou O; Samanta Sennati; Lida Politi; Antonio Cannatelli; Themeli-Digalaki K; Tommaso Giani; Athanassios Tsakris; Gian Maria Rossolini; Spyros Pournaras
ABSTRACT Carbapenem-resistant Klebsiella pneumoniae causes important health care-associated infections worldwide. An outbreak of sequence type 11 (ST11) OXA-48-producing K. pneumoniae (OXA-48-Kp) isolates occurred in Tzaneio Hospital in 2012 and was contained until 2014, when OXA-48-Kp reemerged. The present study involved 19 bloodstream infection (BSI) OXA-48-Kp isolates recovered from 19 intensive care unit (ICU) patients hospitalized between August 2014 and July 2016. MICs were determined by broth microdilution. Beta-lactamase genes were detected by PCR. All isolates were typed by pulsed-field gel electrophoresis/multilocus sequence typing (PFGE/MLST), and 10 representative isolates were typed by next-generation sequencing (NGS). Of the 19 study patients, 9 had previous hospitalizations, and 10 carried OXA-48-Kp prior to BSI isolation; median time from ICU admission to BSI was 29 days. Four OXA-48-Kp isolates belonged to PFGE profile A (ST147) and were pandrug resistant (PDR), while 15 isolates exhibited PFGE profile B (ST101) and were extensively drug resistant. Genes detected via NGS resistome analysis accounted for most of the resistance phenotypes, except for tigecycline and fosfomycin. Insertional inactivation of mgrB (distinct per clone) conferred colistin resistance in all 19 isolates. NGS single nucleotide polymorphism (SNP) analysis validated the clonal relatedness of the ST147 and ST101 strains and revealed the possible presence of two index ST147 strains and the microevolution of ST101 strains. Distinct, but highly related, IncL OXA-48-encoding plasmid lineages were identified; plasmids of the ST147 strains were identical with the plasmid of ST11 OXA-48-Kp which caused the 2012 outbreak. In conclusion, biclonal circulation of OXA-48-Kp and, alarmingly, emergence of a PDR clone are reported. These observations, along with the challenging phenotypic detection of OXA-48 producers and the high reported transmissibility of blaOXA-48, necessitate intensive efforts to prevent their further spread.
Clinical Microbiology and Infection | 2017
M. Coppi; Antonio Cannatelli; Alberto Antonelli; I. Baccani; V. Di Pilato; Samanta Sennati; Tommaso Giani; Gian Maria Rossolini